1 RELX Group Plc
RELX is a global provider of information-based analysis and decision-making tools to professional and business customers, enabling them to make better decisions, achieve better results, and work more efficiently.
RELX’s purpose is to benefit society by developing products that help researchers advance scientific knowledge; doctors and nurses improve the lives of patients; lawyers promote the rule of law and achieve just and fair outcomes for clients; businesses and governments prevent fraud; and consumers access financial services. and receive fair insurance prices; customers understand the market and complete transactions.
Table Company Profiles
Item | Profile |
Company Name | RELX Group Plc |
Website | |
Established Time | 1993 |
Business Distribution Region | Worldwide |
Contact Information | Tel: +44 20 7166 5500 Add: Grand Buildings 1-3 Strand LONDON, WC2N 5JR United Kingdom |
Table Service Introduction
|
SCIENTIFIC, TECHNICAL & MEDICAL Scientific, Technical & Medical helps researchers and healthcare professionals advance science and improve health outcomes by combining quality information and data sets with analytical tools to facilitate insights and critical decision-making. We help researchers share knowledge, collaborate, find funding opportunities and make discoveries. We deliver analysis and insights that help universities, research institutions, governments and funders achieve their strategic goals. We help doctors and nurses improve the lives of patients, providing insights and tools to find the right clinical answers. |
From 2018 to 2023, RELX Group Plc’s revenue in the scientific and technical publication sector showed a moderate growth trend. The company’s revenue increased from $1697.2 million in 2018 to $1853.5 million in 2023, reflecting a compound annual growth rate of approximately 2.27%. This steady growth indicates a consistent expansion in the company’s market presence and revenue generation within the industry over the five-year period.
Figure Revenue and Growth Rate 2018-2023
Between 2018 and 2023, RELX Group Plc’s gross revenue in the scientific and technical publication industry exhibited a steady upward trend, increasing from $766.8 million to $841.4 million. This growth signifies the company’s expanding financial performance in this sector. Concurrently, the gross margin remained relatively stable, hovering around 45%, with a slight increase from 45.18% in 2018 to 45.39% in 2023. This indicates that RELX Group Plc has successfully maintained a strong profitability margin throughout the period, showcasing the efficiency of their operations and their ability to convert revenues into profits in the scientific and technical publication market.
Table RELX Group Plc Revenue, Gross and Gross Margin 2018-2023
RELX Group Plc | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Value (M USD) | 1697.2 | 1751.5 | 1742.8 | 1678.7 | 1822.6 | 1853.5 |
Gross (M USD) | 766.8 | 789.3 | 786.8 | 761.2 | 827.0 | 841.4 |
Gross Margin | 45.18% | 45.07% | 45.14% | 45.35% | 45.37% | 45.39% |
2 Springer
Springer is a leading global scientific, technical and medical portfolio, providing researchers in academia, scientific institutions and corporate R&D departments with quality content through innovative information, products and services. Springer has one of the strongest STM and HSS eBook collections and archives, as well as a comprehensive range of hybrid and open-access journals and books under the SpringerOpen imprint.
Springer is part of Springer Nature, a global publisher that serves and supports the research community. Springer Nature aims to advance discovery by publishing robust and insightful science, supporting the development of new areas of research and making ideas and knowledge accessible around the world. As part of Springer Nature, Springer sits alongside other trusted brands like Nature Research, BMC and Palgrave Macmillan.
Table Company Profiles
Item | Profile |
Company Name | Springer |
Website | |
Established Time | 1842 |
Business Distribution Region | Worldwide |
Contact Information | Add: Heidelberger Platz 3 14197, Berlin, Berlin Germany |
Table Service Introduction
|
Breast and ovarian cancer: There is no adequate therapy without molecular genetic testing Molecular genetics is driving oncology significantly forward. This also applies to breast cancer. But in Germany, molecular genetic testing is still not carried out on many patients – despite its therapeutic relevance. The human geneticist Elke Holinski-Feder and the gynecologic oncologist Michael Untch explain which molecular genetic diagnostics should be standard in gyneco-oncology today. |
Over the period from 2018 to 2023, Springer’s revenue in the scientific and technical publication market experienced a moderate growth trajectory. The revenue increased from $1,088.1 million in 2018 to $1,170.1 million in 2023. This growth indicates a steady performance and expansion within the industry over the five-year period, highlighting Springer’s ability to adapt and thrive amidst evolving market conditions. The compound annual growth rate, while gradual, demonstrates the company’s consistent financial progression and its sustained presence in the scientific and technical publication segment.
Figure Revenue and Growth Rate 2018-2023
Spanning the years from 2018 to 2023, Springer’s gross revenue in the scientific and technical publication sector showed a consistent upward trend, increasing from $467.3 million in 2018 to $499.9 million in 2023. This growth reflects the company’s ability to enhance its earnings through effective strategies and a strong market presence. Throughout this period, Springer’s gross margin remained relatively stable, averaging around 42.7%, with slight fluctuations indicating a solid profitability level. The gross margin’s stability suggests that Springer has successfully managed its operational costs while maintaining competitive pricing, allowing for sustained profitability despite the challenges in the publishing industry. Overall, the growth in gross revenue combined with a stable gross margin underscores Springer’s effective business model and its resilience in the scientific and technical publication market.
Table Springer Revenue, Gross and Gross Margin 2018-2023
Springer | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Value (M USD) | 1088.1 | 1120.4 | 1025.4 | 1083.8 | 1150.2 | 1170.1 |
Gross (M USD) | 467.3 | 481.2 | 439.2 | 464.6 | 492.8 | 499.9 |
Gross Margin | 42.94% | 42.95% | 42.83% | 42.87% | 42.84% | 42.72% |
3 John Wiley & Sons
John Wiley & Sons (Wiley) is a global leader in scientific research and career-connected education, unlocking human potential by enabling discovery, powering education, and shaping workforces. Its online publishing platform Literatum delivers integrated access to more than 10 million articles from approximately 2,100 journals as well as over 27,000 online books and hundreds of multi-volume reference works, laboratory protocols, and databases. Journal subscriptions are primarily licensed through contracts for digital content available via its Wiley Online Library platform. It also engages in co-publishing titles with international publishers and receive licensing revenue from photocopies, reproductions, translations, and digital uses of its content and use of the Knewton adaptive engine. About half of its revenue comes from the US.
Table Company Profiles
Item | Profile |
Company Name | John Wiley & Sons |
Website | |
Established Time | 1807 |
Business Distribution Region | Worldwide |
Contact Information | Add: 111 River St Hoboken, NJ, 07030-5790 United States |
Table Service Introduction
|
Handoff performance analysis of PMIPv6-based distributed mobility management protocol-urban scenario Mobility management allows the networks to track down a mobile user’s location for sending datagrams and to retain the connection when the user changes its location points repeatedly. Whenever a node switches between one base station and another, the connectivity is maintained through a process called handoff management. For real-time traffic implementations in wireless network communications, handover performance is essential. A mobile node is blocked from transmitting and receiving a datagram for a longer time as the handover delay increases. Unacceptable handover delays are common in real-time communication services. To guarantee smooth connectivity and continuous provision of services, effective handoff methods are required. The handoff efficiency of network-based distributed mobility management (DMM) is studied extensively in this article, along with a comparison to PMIPv6. We specifically investigate how handover delay, session recovery, and packet loss are influenced by cell radius. From the analytical and simulation findings this paper concludes that network-based DMM performs better than PMIPv6. |
John Wiley & Sons exhibited a steady upward trend in terms of revenue from 2018 to 2023 in the domain of scientific and technical publishing. Commencing with $965.1 million in 2018, the revenue figure climbed to $970.5 million by 2023. This indicates a consistent and reliable financial progression for the company. The incremental growth, despite minor yearly variations, underscores the company’s capacity to navigate the dynamic scientific publishing industry and maintain a competitive edge. This trajectory reflects John Wiley & Sons’ ongoing commitment to delivering high-quality research and educational materials, marking them as a stalwart in their field amidst shifting market dynamics.
Figure Revenue and Growth Rate 2018-2023
Throughout the years spanning 2018 to 2023, John Wiley & Sons recorded a gross revenue that fluctuated slightly but remained relatively stable, starting at $397.3 million in 2018 and ending at $400.8 million in 2023. This indicates a controlled and consistent financial performance in terms of gross earnings within the scientific and technical publication market. Concurrently, the gross margin sustained a narrow range, beginning at 41.17% in 2018 and concluding with 41.30% in 2023. The maintenance of this margin percentage signifies John Wiley & Sons’ effective cost management and pricing strategies, ensuring a steady profitability across the years despite potential market volatilities. Collectively, the gross revenue and margin figures reflect the company’s financial steadiness and operational efficiency in the competitive landscape of scientific and technical publishing.
Table John Wiley & Sons Revenue, Gross and Gross Margin 2018-2023
John Wiley & Sons | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Value (M USD) | 965.1 | 1007.0 | 948.8 | 1008.9 | 943.0 | 970.5 |
Gross (M USD) | 397.3 | 412.7 | 390.2 | 414.1 | 388.0 | 400.8 |
Gross Margin | 41.17% | 40.99% | 41.13% | 41.05% | 41.15% | 41.30% |
